JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

Search

KKR & Co LP

Ouvert

SecteurFinance

113.28 1.11

Résumé

Variation du prix de l'action

24h

Actuel

Min

111.62

Max

114.01

Chiffres clés

By Trading Economics

Revenu

784M

1.4B

Ventes

-1.5B

3.2B

P/E

Moyenne du Secteur

29.863

20.525

BPA

1.32

Rendement du dividende

0.71

Marge bénéficiaire

43.254

Employés

4,834

EBITDA

45M

2.5B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+31.54% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.71%

4.36%

Prochains Résultats

1 mai 2025

Date du Prochain Détachement de Dividende

12 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-26B

95B

Ouverture précédente

112.17

Clôture précédente

113.28

Score Technique

By Trading Central

Confiance

Very Strong Bullish Evidence

KKR & Co LP Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 avr. 2025, 06:50 UTC

Acquisitions, Fusions, Rachats

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

14 avr. 2025, 11:46 UTC

Acquisitions, Fusions, Rachats

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1 Billion Deal

9 avr. 2025, 10:24 UTC

Acquisitions, Fusions, Rachats

EQT to Sell Karo Healthcare to KKR

9 avr. 2025, 07:09 UTC

Acquisitions, Fusions, Rachats

Assura Accepts $2 Billion Takeover Offer From KKR Consortium

9 avr. 2025, 06:02 UTC

Acquisitions, Fusions, Rachats

KKR Nears $2.85 Billion Deal With EQT For E45 Maker Karo Healthcare, FT Reports, Citing Sources

7 avr. 2025, 14:42 UTC

Acquisitions, Fusions, Rachats

Assura Agrees to Primary Health Properties Bid Deadline Extension

4 avr. 2025, 10:15 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4 avr. 2025, 09:39 UTC

Acquisitions, Fusions, Rachats

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

3 avr. 2025, 14:57 UTC

Acquisitions, Fusions, Rachats

Primary Health Proposes $1.95 Billion Bid for Assura -- Update

3 avr. 2025, 07:17 UTC

Acquisitions, Fusions, Rachats

Primary Health Proposes $1.95 Billion Bid for Assura

22 avr. 2025, 06:04 UTC

Acquisitions, Fusions, Rachats

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22 avr. 2025, 06:03 UTC

Acquisitions, Fusions, Rachats

KKR: Biotage Board Recommends Shareholders Accept Offer

22 avr. 2025, 06:02 UTC

Acquisitions, Fusions, Rachats

KKR: Offer Values Biotage at SEK11.61B

22 avr. 2025, 06:02 UTC

Acquisitions, Fusions, Rachats

KKR Makes SEK145 a Share Bid For Biotage

18 avr. 2025, 00:00 UTC

Actualités

Private Equity World Engulfed by Perfect Storm -- WSJ

14 avr. 2025, 11:31 UTC

Actualités
Acquisitions, Fusions, Rachats

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1B Deal

14 avr. 2025, 11:02 UTC

Acquisitions, Fusions, Rachats

KKR: Making OSTTRA Investment Primarily Through North America Private-Equity Strategy >KKR

14 avr. 2025, 11:01 UTC

Acquisitions, Fusions, Rachats

S&P Global, CME to Divide Sale Proceeds Evenly Pursuant to 50/50 Joint Venture >SPGI CME

14 avr. 2025, 11:00 UTC

Acquisitions, Fusions, Rachats

S&P Global, CME Group to Sell OSTTRA to KKR for $3.1 Billion >SPGI CME KKR

14 avr. 2025, 11:00 UTC

Acquisitions, Fusions, Rachats

S&P Global and CME Group to Sell OSTTRA to KKR for $3.1 Billion

11 avr. 2025, 11:56 UTC

Acquisitions, Fusions, Rachats

KKR Now Owns 30% of Enilive

11 avr. 2025, 11:55 UTC

Acquisitions, Fusions, Rachats

KKR Completes Acquisition of Additional Stake in Enilive

9 avr. 2025, 09:51 UTC

Acquisitions, Fusions, Rachats

EQT to Sell Karo Healthcare to KKR for an Undisclosed Amount

9 avr. 2025, 09:32 UTC

Acquisitions, Fusions, Rachats

EQT: Transaction Expected to Close in Coming Months

9 avr. 2025, 09:31 UTC

Acquisitions, Fusions, Rachats

EQT to Sell Karo Healthcare to KKR

3 avr. 2025, 08:17 UTC

Market Talk
Acquisitions, Fusions, Rachats

Primary Health Properties' Lower Bid for Assura Is a Calculated Risk -- Market Talk

28 mars 2025, 09:34 UTC

Acquisitions, Fusions, Rachats

Topcon: Tender Offer Expected to Start Around End-July >7732.TO

28 mars 2025, 09:33 UTC

Acquisitions, Fusions, Rachats

Topcon: CEO Takashi Eto Also Plans to Participate in Tender Offer, Make Reinvestment After Completion of Offer >7732.TO

28 mars 2025, 09:31 UTC

Acquisitions, Fusions, Rachats

Topcon: JICC Plans to Indirectly Hold Voting Rights in Topcon >7732.TO

28 mars 2025, 09:31 UTC

Acquisitions, Fusions, Rachats

Topcon: KKR Plans to Indirectly Hold Majority Interest in Topcon >7732.TO

Comparaison

Variation de prix

KKR & Co LP prévision

Objectif de Prix

By TipRanks

31.54% hausse

Prévisions sur 12 Mois

Moyen 140.5 USD  31.54%

Haut 194 USD

Bas 114 USD

Basé sur 12 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

12 ratings

11

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

101.87 / N/ASupport & Résistance

Court Terme

Very Strong Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Weak Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos KKR & Co LP

KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market, and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and m